Assessment of selected oxidative stress parameters in patients with Wilson's disease

Archives of Medical Science

Volumn 5, Issue 3, 2009, Pages 465-470

  Świa̧tkowska Stodulska, Renata ^a   Dejneka, Wojciech ^a   Owczarzak, Anna ^a   Drobińska Jurowiecka, Anna ^a   Kiszkis, Hanna ^b   Wiśniewski, Piotr ^a   Sworczak, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Hospital for Infectious Diseases   (Poland)

Author keywords

Antioxidative status; Glutathione peroxidase; Selenium; Superoxide dysmutase; Wilson's disease

Indexed keywords

COPPER; GLUTATHIONE PEROXIDASE; SELENIUM; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; COPPER METABOLISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ERYTHROCYTE LEVEL; FEMALE; HUMAN; LIVER INJURY; MALE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REMISSION; SPECTROPHOTOMETRY; URINARY EXCRETION; WILSON DISEASE;

EID: 73449099604     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Brewer GJ. Recognition, diagnosis, and management of Wilson's disease. Proc Exp Biol Med 2000; 223: 39-46.
2. Britton RS. Metal-induced hepatotoxicity. Semin Liver Dis 1996; 16: 3-12.
3. Murray RK, Granner DK, Mayes PA, Rodwell VW. Harper's Biochemistry. PZWL, Warszawa 1995.
4. Bettger WJ. Zinc and selenium, site-specific versus general antioxidation. Can J Physiol Pharmacol 1993; 71: 721-4.
5. Turan B, Dalay N, Afrasyap L, et al. The effects of selenium supplementation on antioxidative enzyme activities and plasma and erythrocyte selenium levels. Acta Physiol Hung 1993; 81: 87-93.
6. Feher J, Nemeth E, Nagy V, Lengyel G, Feher J. The preventive role of coenzyme Q10 and other antioxidants in injuries caused by oxidative stress. Arch Med Sci 2007; 3: 305-14.
7. Świa̧tkowska-Stodulska R, Dejneka W, Jabłoń ska-Kaszewska I, et al. Serum selenium concentration in patients with Wilson's disease. Hepatogastroenterology 2007; 54: 1788-90.
8. Katsoulis K, Kontakiotis T, Baltopoulos G, Kotsovili A, Legakis IN. Total antioxidant status and severity of community-acquired pneumonia: are they correlated? Respiration 2005; 72: 381-7.
9. Koch OR, Pani G, Borrello S, et al. Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Mol Aspects Med 2004; 25: 191-8.
10. Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002; 27: 63-8.
11. Cemek M, Dede S, Bayiroglu F, Caksen H, Cemek F, Mert N. Relationship between antioxidant capacity and oxidative stress in children with acute hepatitis A. World J Gastroenterol 2006; 12: 6212-5.
12. Popadiuk S, Liberek A, Korzon M, Renke J, Woźniak M. Free radical reactions and activity of antioxidant barrier in children with chronic hepatitis B [Polish]. Med Wieku Rozwoj 2004; 8: 395-402.
13. Czuczejko J, Zachara BA, Staubach-Topczewska E, Halota W, Kȩdziora J. Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases. Acta Biochim Pol 2003; 50: 1147-54.
14. Dworkin BM, Rosenthal WS, Stahl RE, Panesar NK. Decreased hepatic selenium content in alcoholic cirrhosis. Dig Dis Sci 1988; 33: 1213-7.
15. Jabłońska-Kaszewska I, Świa̧tkowska-Stodulska R, Łukasiak J, et al. Serum selenium levels in alcoholic liver disease. Med Sci Monit 2003; 9 (Suppl 3): 15-8.
16. Samuele A, Mangiagalli A, Armentero MT, et al. Oxidative stress and pro-apoptotic conditions in rodent model of Wilson's disease. Biochim Biophys Acta 2005; 1741: 325-30.
17. Nagasaka H, Inoue I, Inui A, et al. Relationship between oxidative stress and antioxidant systems in the liver of patients with Wilson's disease: hepatic manifestation in Wilson's disease as a consequence of augmented oxidative stress. Pediatr Res 2006; 60: 472-7.
18. Dastych M. Serum levels of zinc, copper and selenium in patients with Wilson's disease treated with zinc [Czech]. Vnitr Lek 1999; 45: 217-9.
19. Dalgiç B, Sönmez N, Biberoǧlu G, Hasanoǧlu A, Erbaşş D. Evaluation of oxidant stress in Wilson's disease and non-Wilsonian chronic liver disease in childhood. Turk J Gastroenterol 2005; 16: 7-11.
20. Rodo M, Czonkowska A, Pulawska M, Swiderska M, Tarnacka B, Wehr H. The level of serum lipids, vitamin E and low density lipoprotein oxidation in Wilson's disease patients. Eur J Neurol 2000; 7: 491-4.
21. Yu W, Jia L, Wang P, et al. In vitro and in vivo evaluation of anticancer actions of natural and synthetic vitamin E forms. Mol Nutr Food Res 2008; 52: 447-56.
22. Dong LF, Swettenham E, Eliasson J, et al. Vitamin E analogues inhibit angiogenesis by selective induction of apoptosis in proliferating endothelial cells: the role of oxidative stress. Cancer Res 2007; 67: 11906-13.
23. Attri S, Sharma N, Jahagirdar S, Thapa BR, Prasad R. Erythrocyte metabolism and antioxidant status of patients with Wilson's disease with haemolytic anaemia. Pediatr Res 2006; 59: 593-7.
24. Farinati F, Cardin R, D'Inca R, Naccarato R, Sturniolo GC. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease. J Lab Clin Med 2003; 141: 372-7.
25. Sturniolo GC, Mestriner C, Irato P, Albergoni V, Longo G, D'Inca R. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients. Am J Gastroenterol 1999; 94: 334-8.
26. Santon A, Irato P, Medici V, D'Inca R, Albergoni V, Sturniolo GC. Effect and possible role of Zn treatment in LEC rats, an animal model of Wilson's disease. Biochim Biophys Acta 2003; 1637: 91-7.
27. Galanter WL, Hakimian M, Labotka RJ. Structural determinants of substrate specificity of the erythrocyte anion transporter. Am J Physiol 1993; 265: C918-26.